Potential diagnostic value of PD‐1 in peripheral blood mononuclear cells of postmenopausal osteoporosis patients

BACKGROUND: Postmenopausal osteoporosis (PMOP) is an estrogen deficiency‐induced skeletal disorder. Bone mineral density (BMD) testing is the gold standard for diagnosing osteoporosis. However, its sensitivity for fracture risk assessment is low. Programmed cell death protein 1 (PD‐1) is a key immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Xiu‐Ping, Zhao, Qing, Guo, Zhao‐Di, Lin, Shao‐Jun, Chen, Zhi‐Xiang, Chen, Min‐Yuan, Zheng, Lei, Zhao, Ke‐Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307364/
https://www.ncbi.nlm.nih.gov/pubmed/32065479
http://dx.doi.org/10.1002/jcla.23223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307364/
https://www.ncbi.nlm.nih.gov/pubmed/32065479
http://dx.doi.org/10.1002/jcla.23223

Ejemplares similares